their RWD and continuous improvement model bringing 'agile' into the drug development process. should really boost their learnings. this trial is arguably got backing of 10,000 additional patents across like 150 indications.
1+1 learning to feed into the trial.
data that is captured correctly and ethically.
- Forums
- ASX - By Stock
- EMD
- general talk
general talk, page-99
-
- There are more pages in this discussion • 281 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
-0.002(5.88%) |
Mkt cap ! $13.29M |
Open | High | Low | Value | Volume |
3.5¢ | 3.5¢ | 3.2¢ | $13.66K | 397.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 177108 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 75371 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 177108 | 0.032 |
5 | 144518 | 0.031 |
9 | 905619 | 0.030 |
4 | 110414 | 0.029 |
2 | 23000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 75371 | 1 |
0.038 | 50000 | 1 |
0.042 | 64500 | 1 |
0.043 | 12000 | 1 |
0.044 | 20000 | 1 |
Last trade - 15.54pm 13/11/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online